Evidence map›Paper›PMID 25302615›Full record

ReviewInternational journal of molecular sciences2014

Novel formulations for antimicrobial peptides.

Ana Maria Carmona-Ribeiro, Letícia Dias de Melo Carrasco

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 130 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Natural Antimicrobials forMicroorganisms · 2023
    Review
  7. Review
  8. Transgenic Sweet Orange Expressing theInternational journal of molecular sciences · 2022
    Article
  9. Article
  10. Supramolecular Nanostructures for Vaccines.Biomimetics (Basel, Switzerland) · 2021
    Review
  11. Review
  12. Antimicrobial Polymer-Based Assemblies: A Review.International journal of molecular sciences · 2021
    Review
  13. Review
  14. Review
  15. Antimicrobial peptide polymers: no escape to ESKAPE pathogens-a review.World journal of microbiology & biotechnology · 2020
    Review
  16. Cationic Nanostructures for Vaccines Design.Biomimetics (Basel, Switzerland) · 2020
    Review
  17. Review
  18. Review
  19. Polymyxin Delivery Systems: Recent Advances and Challenges.Pharmaceuticals (Basel, Switzerland) · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ana Maria Carmona-RibeiroBiocolloids Laboratory, Instituto de Química, Universidade de São Paulo, Av. Lineu Prestes 748, 05508-000 São Paulo, SP, Brazil. amcr@usp.br.
Letícia Dias de Melo CarrascoBiocolloids Laboratory, Instituto de Química, Universidade de São Paulo, Av. Lineu Prestes 748, 05508-000 São Paulo, SP, Brazil. lemelodias@usp.br.
Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptides in general hold much promise as a major ingredient in novel supramolecular assemblies. They may become essential in vaccine design, antimicrobial chemotherapy, cancer immunotherapy, food preservation, organs transplants, design of novel materials for dentistry, formulations against diabetes and other important strategical applications. This review discusses how novel formulations may improve the therapeutic index of antimicrobial peptides by protecting their activity and improving their bioavailability. The diversity of novel formulations using lipids, liposomes, nanoparticles, polymers, micelles, etc., within the limits of nanotechnology may also provide novel applications going beyond antimicrobial chemotherapy.

Indexed as

Anti-Infective AgentsAntimicrobial Cationic PeptidesBacteriaBiocompatible MaterialsChemistry, PharmaceuticalCyclosporineDrug CarriersHumansLipid BilayersAnti-Infective AgentsAntimicrobial Cationic PeptidesBiocompatible MaterialsCyclosporineDrug CarriersLipid Bilayers

Identifiers

PMID25302615
PMCPMC4227203
OpenAlexW2129939988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.